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Abstract
Excessive production of monoclonal light chains due to multiple myeloma can induce aggregation-related disorders, such
as light chain amyloidosis (AL) and light chain deposition diseases (LCDD). In this work, we produce a non-amyloidogenic
IgE l light chain dimer from human mammalian cells U266, which originated from a patient suffering from multiple
myeloma, and we investigate the effect of several physicochemical parameters on the in vitro stability of this protein. The
dimer is stable in physiological conditions and aggregation is observed only when strong denaturating conditions are
applied (acidic pH with salt at large concentration or heating at melting temperature Tm at pH 7.4). The produced
aggregates are spherical, amorphous oligomers. Despite the larger b-sheet content of such oligomers with respect to the
native state, they do not bind Congo Red or ThT. The impossibility to obtain fibrils from the light chain dimer suggests that
the occurrence of amyloidosis in patients requires the presence of the light chain fragment in the monomer form, while
dimer can form only amorphous oligomers or amorphous deposits. No aggregation is observed after denaturant addition at
pH 7.4 or at pH 2.0 with low salt concentration, indicating that not a generic unfolding but specific conformational changes
are necessary to trigger aggregation. A specific anion effect in increasing the aggregation rate at pH 2.0 is observed
according to the following order: SO4
2&Cl
2.H2PO4
2, confirming the peculiar role of sulfate in promoting protein
aggregation. It is found that, at least for the investigated case, the mechanism of the sulfate effect is related to protein
secondary structure changes induced by anion binding.
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Introduction
The aggregation stability of the immunoglobulin light chain
fragments is involved in several disorders related to the abnormal
proliferation of bone marrow monoclonal plasma B cells and the
subsequent excessive production of monoclonal light chains. 10–15%
ofthe patients affected by multiple myeloma and with large light chain
serum concentration are subsequently affected by the aggregation-
related diseases [1], such as light chain amyloidosis (AL) [2], light
chain deposition diseases (LCDD) [3], and cast nephropathy [4].
Light chain amyloidosis (AL) is the most common form of sporadic
systemic amyloidosis [5,6], characterized by deposition of insoluble
amyloid fibrils in organs such as kidney, heart and liver, which leads to
organ failure; it can act also on peripheral nerve, gastrointestinal track
and lungs [7]. In opposition to the fibrillar structures encountered in
AL, in LCDD the aggregates are amorphous and granular. The
basement membrane of kidney is the main target organ, although also
heart and liver may be affected [8]. Typically, only one of the two
forms of disease occurs in patients [9].
A great challenge in understanding the cause and mechanism of
aggregation is given by the extremely large number of the possible
mutated variant sequences involved. In fact, each patient produces
antibodies which have undergone antigen-driven selection.
Therefore, the heterogeneity of possible diseases and related
protein aggregates are due both to fragment primary sequence and
to environmental factors. Several works show that the k and l
types of light chain dominate in LCDD and AL, respectively [10].
Despite such tentative of classification based on clinical analysis
[11,12], the factors determining whether or not some variants are
pathological or lead to fibrillar aggregates or amorphous deposits
are far from being understood.
In addition to protein structure, protein amount affects
propensity to deposit: circulating disulfide-bound light chain
dimers can interfere with normal clearance and metabolism,
increasing their serum level [11]. Therefore, it is important to
clarify the stability of the dimers and the relationship between
dimer/monomer equilibrium and aggregation mechanism [13].
In this work, we investigate the effect of several physicochemical
parameters on the in vitro aggregation propensity of a l light chain
IgE dimer. This protein was obtained from a human myeloma cell
line U266, coming from a patient suffering from multiple myeloma
in which neither amyloids nor amorphous deposits were detected
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33372[14]. The production of protein in a reasonable amount and in a
reproducible way is often a challenge in protein aggregation
studies. Commonly, light chain variants are produced recombi-
nantly from bacteria [15] or extracted from urine [16]. Despite the
larger effort demanded compared to the commonly employed
bacteria systems, the production from eukaryotic cells allows
avoiding re-folding steps commonly present in the production
from bacteria. Moreover, in the case of glycosilated light chain
variants the use of eukaryotic cells allows the production of
proteins with a glycosylation pattern close to the physiological one.
Although the production of light chain fragment and complete
immunoglobulin by U266 cells has been already studied [17,18],
to our knowledge this is the first aggregation study on proteins
obtained by such cell line.
We applied several biophysical techniques to investigate protein
secondary structure stability and aggregation behavior. Protein
secondary structure was characterized by spectroscopic techniques
such as circular dichroism (CD), intrinsic tryptophan fluorescence
and 8-anilino-1-naphthalenesulfonic acid (ANS) binding, while the
aggregation was monitored by dynamic light scattering (DLS),
thioflavin T (ThT) assay, size exclusion chromatography (SEC)
and asymmetrical field flow fractionation (FFF). Aggregates
morphology was investigated by Congo Red binding, thin film
attenuated total reflectance fourier transform infrared spectrosco-
py (ATR-FTIR) and atomic force microscopy (AFM). The study
shows the relationship between secondary structure and aggrega-
tion for the investigated l light chain dimer and underlines the
importance of environmental factors, particularly the kind and
concentration of salt, on protein stability.
Moreover, we have successfully determined the original full-
length sequence of the monoclonal light chain produced by the
human U266 cell clone. This observation will enable us to make
comparative analysis with other studies describing the features of
immunoglobulin light chains with a known sequence.
Results
Protein characterization
Many domains (both single variable and complete constant-
variable domains) have been found to form dimers in physiological
and stable conditions [16]. Particularly, amyloidogenic light chains
are commonly found to be in equilibrium between the dimer and
the monomeric form in patients’ urine [16]. After the production
and purification step, the protein has been characterized in terms
of monomer-dimer equilibrium at physiological and low pH. The
SEC chromatograms reported in Figure 1A show a single,
symmetric peak under both conditions. According to the column
calibration curve, the elution volume of such a peak corresponds to
a molecular weight of 42 kDa, indicating the presence of a dimer
consisting of both variable and constant domain [1]. The linearity
between the elution volume and the natural logarithm of the
molecular weight applies well only for globular proteins and non-
spherical macromolecules can deviate from such relationship [19].
Therefore, to get a more accurate evaluation of the molecular
weight, mass spectroscopy (MS) analysis was performed. The
results in Figure 1B and 1C show one single peak with molecular
weight equal to 45.7 kDa for both conditions, in agreement with
SEC analysis. It is worth noting that the results of SEC and MS
are inconsistent with the western Blot and SDS-PAGE analysis
(data not shown), which revealed two bands, at around 50 kDa
and 25 kDa. This may arise from the denaturating conditions used
in the electrophoresis analysis, which can induce breakage of the
dimer disulphide-bond. Indeed, when SDS-Page was performed in
the presence of a reducing agent, only the 25 kDa monomer band
was detected. We can conclude that the produced light chains are
composed of both constant and variable part and associate into
dimers through covalent disulphide bonds, which can be broken
under reducing conditions.
The nucleotide sequence of U266 derived IgE l light chain has
been characterized as described in Text S1. Figure S1 reports the
U266 derived IgE l light chain nucleotide sequence, whereas
Figure S2 shows the alignment of the amino acid sequence with
the germline donor IGVL2-8.
In addition, the pI of the protein was measured equal to 8.5–9.0
by isoelectric focusing (data not shown), in agreement with the
theoretical pI (8.25), calculated using a dedicated tool available on
the Expasy proteomic server website (www.expasy.org).
Effect of environmental factors on structure stability and
aggregation behavior
The effect of pH, denaturant and temperature on the structure
stability of the light chain was investigated by spectroscopic
techniques.
In Figure 2A the far-UV CD spectra of the protein at pH 7.4
and pH 2.0 are reported. The spectrum at pH 7.4 shows a
minimum at 220 nm characteristic of the Greek key b-barrel
folding of the immunoglobulin fragment [20,21]. The b-sheet
structure content increases as the pH value decreases from 7.4 to
2.0 and the minimum shifts from 220 to 218 nm.
The unfolded protein fraction as a function of guanidinium
hydrochloride (GuHCl) has been evaluated by intrinsic tryptophan
fluorescence, while the temperature stability of the light chain was
investigated by CD temperature-step measurements (see Materials
and Methods for details). The GuHCl concentration required to
unfold half of the protein (Fu=0.5) is equal to about 1.5 M
(Figure 2B), while the melting temperature (Tm) at physiological
pH was estimated equal to 55uC (Figure 2C).
After characterizing the structural stability of the protein, the
aggregation propensity of the light chain in several conditions was
assessed by DLS. A summary of all the experimental runs is
reported in Table 1, while the corresponding DLS data are shown
in Figure S3. For the condition at low pH, the effect of biologically
relevant salts, i.e. sodium chloride (NaCl), sodium phosphate
(NaH2PO4) and sodium sulphate (Na2SO4), was considered.
In physiological conditions, i.e., 25 mM PBS with 0.15 M NaCl
at pH 7.4 and 37uC (run 1 in Table 1), the protein solutions were
stable for over five months. Also in 20 mM HCl solution at pH 2.0
with or without 0.15 M NaCl or 0.15 M NaH2PO4 no
aggregation could be detected after several days of incubation
(run 2, 3 and 5 in Table 1).
The situation changed when the concentrations of NaCl and
NaH2PO4 were increased to 0.45 M and 0.49 M, respectively (run
4 and 6 in Table 1) or when Na2SO4 was added (runs 7 to 9 in
Table 1). The stability behavior for the different salts and different
salt concentrations, followed by DLS, is shown in Figure 3. In
Figure 3A, the results obtained using different salts but at the same
constant concentration of 0.15 M are compared, while in
Figure 3B salts are compared at similar ionic strength I, being I
defined as I~ 1
2
P n
i~1
ciz2
i , where ci is the concentration of ionic
species and zi the corresponding valence (I is equal to 0.45 M for a
0.45 M NaCl and 0.49 M NaH2PO4 solution, and equal to
0.35 M for a 0.15 M Na2SO4 solution). In all cases where
instability occurred, the scattered intensity increased almost
linearly from the beginning of the incubation, without the lag
phase typically encountered in amyloidogenic systems [22],
indicating that the aggregate formation started immediately after
incubation without a nucleation process. NaH2PO4 followed a
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sufficiently large concentration values, but aggregation was slower
with NaH2PO4 than with NaCl. Instead, Na2SO4 showed a
peculiar effect in accelerating the aggregation at low pH, which
occurred even at low salt concentration (64 mM, corresponding to
an ionic strength of 0.15 M).
To investigate such peculiar effect, the initial light chain
secondary structure in the presence of the sulfate and the chloride
anion was characterized by CD spectroscopy and ANS binding, a
method probing the solvent accessibility of hydrophobic patches.
As shown in Figure 4A, with respect to the case in the absence of
salt, in the presence of NaCl the minimum in the far-UV CD
spectrum is decreased, indicating an increase of b-sheet structure;
moreover, the minimum shifts from 218 to 217 nm. Such
structural rearrangement is accompanied by a burying of
hydrophobic patches, as indicated by the decrease of the
maximum ANS fluorescence (Figure 4B) as a consequence of the
reduced binding of the hydrophobic dye. In the presence of the
sulfate anions, the light chain structure changes significantly: the
far-UV CD spectrum shows a minimum at 204.6 nm, corre-
sponding to a disordered structure (Figure 4A). In such a more
open, disordered structure, with respect to the b-sheet, the
hydrophobic patches expose more in the solvent. Indeed, the
ANS binding in this case is larger than that in the presence of the
chloride anion, as indicated by the increase in maximum ANS
fluorescence (Figure 4B). It is likely that such significant structural
change forms an intermediate more prone to aggregate. On the
other hand, by increasing the salt concentration (by adding
0.45 M NaCl, 0.49 M NaH2PO4 and 0.5 M Na2SO4), the
maximum ANS fluorescence decreases (Figure 4B), indicating less
Figure 1. Protein characterization. (A) SEC chromatogram of 1 g/L light chain solution in 25 mM PBS buffer at pH 7.4 (_) and in 20 mM HCl at
pH 2.0 (–). Insertion: calibration curve obtained with bovine serum albumin (60 kDa), chymotrypsinogen A (25 kDa) and lysozyme (14.5 kDa); (B) and
(C) Mass spectroscopy analysis in 25 mM PBS buffer at pH 7.4 (B) and in 20 mM HCl at pH 2.0 (C).
doi:10.1371/journal.pone.0033372.g001
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effects induced at high salt concentration, which will be discussed
in the Discussion section. Moreover, it is worth noticing that at
0.5 M Na2SO4 the fast aggregation rate affects the ANS
measurements.
Since at low pH the protein is positively charged (pI=8.5–9),
only anions are expected to affect intra and intermolecular
interactions. To verify the absence of the cation effect on
aggregation, an additional experiment in 20 mM HCl at pH 2.0
with 0.45 M KCl was performed (run 11 in Table 1). The result is
compared with that with 0.45 NaCl in Figure 4C, confirming the
absence of the cation effect for the investigated salts.
After considering aggregation at low pH, we have also
investigated temperature- and denaturant-induced aggregation at
physiological pH. Incubation at the melting temperature
Tm=55uC (run 11 in Table 1) caused aggregate formation after
few hours. Instead, incubation in 25 mM PBS at pH=7.4 with
GuHCl in the concentration range from 1.3 to 1.5 M (run 12 and
13 in Table 1) could not induce any aggregation in the presence of
either 0.15 M NaCl or 0.15 M Na2SO4. This result suggests that a
generic partial protein unfolding is insufficient to promote
aggregation, but specific unfolded configurations are necessary to
induce aggregation.
Aggregation pathway and aggregate morphology
The aggregation pathway was investigated by several techniques
taking as a reference condition run 8 in Table 1 (20 mM HCl
buffer at pH 2.0 with 0.15 M Na2SO4,3 7 uC). In Figure 5A the
time evolution of the hydrodynamic radius (,Rh.) followed on-
line by DLS is shown. As mentioned above, the aggregation
induced by the sulfate addition occurs without lag-phase. The
dimer conversion was measured by taking samples at different
times during the aggregation and analyzing them off-line by SEC
and FFF. The results obtained by the two techniques were
consistent, showing a significant decrease of the dimer peak in the
chromatograms over time (data not shown). From the value of the
area under the peak, the amount of the residual massive dimer
Figure 2. Light chain structural changes induced by pH,
denaturant addition and temperature. (A) CD spectra for the
0.3 g/L light chain solution in 25 mM PBS at pH 7.4 (_) and in 20 mM
HCl at pH 2.0 (–); (B) Fraction of unfolded protein as a function of
guanidinium hydrochloride (GuHCl) concentration evaluated by intrin-
sic tryptophan fluorescence measurements (see Materials and Meth-
ods). The continuous line represents the interpolation of experimental
data according to Eq. 1; (C) Fraction of unfolded protein as a function of
temperature evaluated by CD measurements (see Materials and
Methods). The continuous line corresponds to the interpolation of
experimental data according to Eq.1.
doi:10.1371/journal.pone.0033372.g002
Table 1. Summary of all investigated conditions. Protein
concentration is 1 g/L in all cases.
Run Buffer pH Salt T Aggregation
1 25 mM PBS 7.4 0.15 M NaCl 37uC no
2 20 mM HCl 2.0 - 37uC no
3 20 mM HCl 2.0 0.15 M NaCl 37uC no
4 20 mM HCl 2.0 0.45 M NaCl 37uC yes
5 20 mM HCl 2.0 0.15 M NaH2PO4 37uC no
6 20 mM HCl 2.0 0.49 M NaH2PO4 37uC yes
7 20 mM HCl 2.0 0.064 M Na2SO4 37uC yes
8 20 mM HCl 2.0 0.15 M Na2SO4 37uC yes
9 20 mM HCl 2.0 0.5 M Na2SO4 37uC yes
10 20 mM HCl 2.0 0.45 M KCl 37uC yes
11 25 mM PBS 7.4 - 55uC yes
12 25 mM PBS 7.4 0.15 M NaCl + 1.3 to
1.5 M GnHCl
37uC no
13 25 mM PBS 7.4 0.15 M Na2SO4 + 1.5 M
GnHCl
37uC no
14 25 mM PBS 7.4 0.15 M Na2SO4 + seeds 37uC no
doi:10.1371/journal.pone.0033372.t001
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the dimer conversion is almost completed already after 6 hours
while aggregation is still on-going (Figure 5A). This implies that
aggregation does not occur via dimer addition only but also among
larger aggregates. However, larger aggregates could not be
detected with neither of the two techniques mentioned above,
probably because of interactions with the stationary phases of the
two instruments.
The change of secondary structure during aggregation was
followed by spectroscopic techniques (intrinsic tryptophan, CD
and ThT fluorescence). The intrinsic tryptophan spectra showed
an increase in the maximum fluorescence value over time
(Figure 5C), indicating that, as a consequence of structural
rearrangements, the tryptophan residues exposed during denatur-
ation at low pH become less solvent-exposed during the
aggregation. The change in the protein secondary structure along
the aggregation is confirmed by CD spectroscopy, as shown in
Figure 5D. The far-UV CD spectra show a progressive significant
shift from a random-coil structure to a more ordered b-sheet
structure, with the minimum shifted from 205 to 216 nm.
Despite the formation of more ordered b-sheet structure during
aggregation, the aggregates showed low ThT signal increment
Figure 3. Light scattering intensities measured on-line by in situ
DLS. (A) 1 g/L light chain solution in 20 mM HCl buffer at pH 2.0
without salt (n), with 0.15 M NaCl (–), NaH2PO4 (...), Na2SO4 (_) (runs 3,
4, 6 and 9 in Table 1); (B) The same as (A) but salts are compared at
similar ionic strength (see text): 0.45 M NaCl (–), 0.49 M NaH2PO4 (...),
0.15 M Na2SO4 (_) (runs 4, 6 and 8 in Table 1); (C) The same as (A) but for
a solution in 20 mM HCl buffer at pH 2.0, with 0.45 M NaCl (_) and KCl
(...) (runs 4 and 10 in Table 1).
doi:10.1371/journal.pone.0033372.g003
Figure 4. Light chain structural changes induced by salt
addition monitored by CD (A) and ANS binding (B). Experiments
were performed at 20uC for a 0.3 g/L protein solution in 25 mM PBS at
pH 7.4 (...) and in 20 mM HCl buffer at pH 2.0 without salt (n), with
0.15 M NaCl (–),0.15 M Na2SO4 (_), 0.45 M NaCl (#), 0.49 M NaH2PO4
(%) and 0.5 M Na2SO4 (6).
doi:10.1371/journal.pone.0033372.g004
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binding (see Figure S4). The increase in solution turbidity was
significant already after one day incubation. However, while the
increase of the light scattering intensity was large, the increase of
ThT absolute fluorescence values was small even after three weeks
of incubation. After such period, aggregates were analyzed also
with Congo Red test, the most common and efficient test applied
to detect the presence of fibrils of light chain [23]. The result of the
test was negative, confirming the absence of fibrillar structure (see
Figure S5).
The aggregate morphology was further studied by AFM
microscopy and hydrated thin film ATR-FTIR. In Figure 6 the
pictures of samples taken after one month incubation in the
conditions of runs 4, 6, 8 and 11 in Table 1 are shown. It can be
seen that only spherical aggregates are visible for all the
investigated conditions.
FTIR spectra of native state dimer and protein aggregates are
reported in Figure 7, where the spectrum of the native dimer
shows a maximum at 1641 cm
21, characteristic of the b-sheet
structure of the immunoglobulin fragment and corresponding to
the minimum at 220 nm in CD spectrum in Figure 2A. The
spectrum shows also a significant presence of disordered, a-helix
and turns/loops structure, corresponding to the area between
1647 and 1695 cm
21, in analogy to other spectra of variable
domain reported in literature [24,25,26]. In the aggregate spectra
the percentage of the area between wavenumbers 1615 and
1640 cm
21 with respect to the total area increases and the
maximum shifts to 1635.4 cm
21. Such changes indicate rear-
rangement of the secondary structure inside the aggregates and,
particularly, an increase of the b-sheet structure content with
respect to the native state, in agreement with the intrinsic
tryptophan fluorescence and the CD data shown in Figure 5C
and 5D, respectively. Nevertheless, the disordered, a-helix and
turns/loops structures are still significantly present, and the
absence of the predominance of the b-sheet structure confirms
again the non-amyloidogenic nature of the formed aggregates.
The shift of the maximum is less pronounced in the case of
NaH2PO4, due to the slower aggregation kinetics.
The ability of the obtained aggregates to seed aggregation was
investigated by adding fragments of aggregates obtained in 20 mM
HCl buffer at pH 2.0 with 0.5 M Na2SO4 to a 1 g/L light chain
solution. The aggregates were broken by sonication as reported by
Kim et al. [27] using two different sonication times of 0.5 and
5 minutes. The seeds were added at a concentration of 0.1 and
Figure 5. Aggregation kinetics of light chain solution in 20 mM HCl at pH 2.0, T=376C, with 0.15 M Na2SO4 (run 8 in Table 1). Time
evolutions of (A) the average hydrodynamic radius ,Rh., measured on-line by in situ DLS; (B) residual massive dimer fraction (m) evaluated by SEC
(&) and FFF (#); (C) Intrinsic tryptophan spectra; (D) CD spectra. Experiments were performed at a protein concentration of 1 g/L for (A) and (B) and
0.3 g/L for (C) and (D).
doi:10.1371/journal.pone.0033372.g005
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Table 1): no aggregation was observed after several months. The
results indicate that amorphous aggregates alone are unable to
induce aggregation under the conditions where the peculiar,
partially unfolded, configuration necessary to trigger aggregation is
absent.
Discussion
In many studies related to protein aggregation it has been
shown that the secondary structure thermodynamic stability and in
vitro fibril formation propensity are strongly related
[13,27,28,29,30]. Temperature, pH and denaturants, such as
urea and guanidinium hydrochloride, at suitable concentrations
may promote protein conformation changes, particularly total or
partial protein unfolding, leading to aggregation [20,31,32,33].
The aggregation mechanism and kinetics as well as the
morphology of the final products have been shown to depend
on the specific unfolded intermediate structure [34,35,36,37]. For
instance, Khurana et al. [29] studied the aggregation of a
recombinant non-amyloidogenic light chain variant (stable in
physiological conditions) induced by pH, and found that
amorphous aggregates were obtained at pH between 3 and 4,
while at pH 2 fibrillar structures were formed. In another study
[9], the morphology of the aggregates obtained in vitro by a single
variant was significantly affected by the chemical composition of
biologically relevant lipid-derived aldehydes added into the system.
Also in this case, aggregation occurred via protein secondary
structure changes. These examples clearly underlined the
important role played by the protein secondary structure in the
delicate balance between electrostatic and hydrophobic interac-
tions responsible for the protein stability [38].
Another physical factor significantly affecting the stability
behavior of the light chain is the protein native oligomeric state,
i.e., monomer, dimer, and their equilibrium state. In the case of an
amyloidogenic variant a single amino acid mutation located at the
dimer interface could cause a significant difference in the dimer
stability, shifting the equilibrium versus the monomer and
Figure 6. Aggregates morphology. AFM pictures of light chain aggregates obtained after one month incubation in 20 mM HCl at pH 2.0 with
0.45 M NaCl (A), with 0.15 M Na2SO4 (B) or with 0.49 M NaH2PO4 (C) and after two hours incubation in 25 mM PBS at pH 7.4, T=55uC (D) (runs 4, 8, 6
and 11 in Table 1).
doi:10.1371/journal.pone.0033372.g006
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that fibril formation kinetics was accelerated when monomer-
dimer equilibrium was shifted versus monomer by decreasing the
total protein concentration or by denaturant addition [13,20,40].
In the proposed aggregation schemes, fibrillation proceeded only
via monomer addition, while dimers were responsible for the off-
pathway amorphous oligomers observed together with amyloid
fibrils.
The results shown in this work indicate that the light chain
dimer is very stable in physiological conditions and dimer
denaturation is a necessary but not sufficient condition to induce
aggregation. This follows from our observation that protein
denaturation either by shifting the pH from 7.4 to 2 or by adding
GuHCl at physiological pH was not resulting in any instability.
Instead, aggregation was observed at low pH when salt was added
at large concentrations or at physiological pH when the solution
was heated to the protein Tm. The results indicate that a specific
configuration change is necessary to induce aggregation in
globular proteins.
From a kinetic point of view, we observed that when
aggregation occurs it starts immediately after incubation without
any induction period, as indicated by DLS data (Figures 3 and
5A). The aggregation is accompanied by structural rearrange-
ments which decrease the solvent exposure of tryptophan residues
(Figure 5C) and increase the protein b-sheet content (CD data in
Figure 5D). Such increase in the b-sheet content in the aggregates
compared to the native state is confirmed by FTIR analysis
(Figure 7). Despite such increase, the aggregates retain a large
amount of random coil, a-helix and loops structures and do not
bind ThT or Congo Red dye as amyloid fibrils do. AFM confirms
the absence of fibrils and shows the presence of amorphous
spherical aggregates (Figure 6). Moreover, the addition of such
amorphous aggregates in native proteins is unable to induce
aggregation in physiological conditions, most probably because
they cannot induce the necessary conformational change in the
native fold protein. At least for the reference reaction (run 9 of
Table 1) in FFF and SEC chromatograms, the decrease in the
dimer peak was not accompanied by the increase in the monomer
peak, indicating that aggregation was not occurring via monomer
formation. The lack of monomer formation and the absence of
fibrils suggest that the monomer is the only repetitive unit present
in the pathway to amyloid fibrils, while dimers are responsible for
amorphous aggregates.
Considering the experimental evidences previously discussed,
we proposed the reaction scheme shown in Figure 8: under
suitable conditions the native dimer is partially denatured into a
reactive species D*, which may be in equilibrium with the native
dimer D. D* has suitable conformational characteristics to
aggregate further irreversibly into larger amorphous aggregates.
Of particular interest is the fact that one of the few conditions
where aggregation was observed is the addition of salt at low pH.
Salt-induced aggregation at low pH has been observed also for a
complete monoclonal immunoglobulin IgG2: at pH 3 with NaCl
in the concentration range 0.1–0.5 M, partial unfolding of the
antibodies followed by reversible aggregation to oligomers was
observed [41]. The effect of the salt on the stability of the light
chain dimer and of the intact immunoglobulin can be explained by
a combination of several factors. First of all, salt ions at low salt
concentration screen the repulsive electrostatic interactions
between proteins, as described by the DLVO (Derjaguin-
Landau-Vervey-Overbeek) theory, which quantifies the mean-
field interaction potential between two approaching particles
considering only Van der Waals and non-specific electrostatic
interactions [42]. Second, at the high concentrations considered in
this work (0.15–0.45 M), additional, anion binding effects must be
considered, which may change the protein surface chemistry and
therefore the protein secondary structure, inducing a conforma-
tion more prone to aggregate. Further, salt-protein preferential
exclusion may lead to salting-out effect, resulting in protein
precipitation [43]. Unlike unspecific salt screening effects, such
effects are strongly ion specific. In this work only anions have been
found to affect aggregation kinetics, while the investigated
monovalent cations (Na and K) do not have any effect. The
specific anion effect on several biological phenomena has been
widely reported in the literature and often compared to the so-
called Hofmeister series [44] based on anion capacity to affect
protein stability, protein precipitation and water structure. Despite
the large use of the Hofmeister series, its molecular origin is still
under debate [42]. When compared at the same concentration
and similar ionic strength, the order of the anions in accelerating in
vitro light chain aggregation found in this work is:
SO4
2.Cl
2.H2PO4
2, somehow in disagreement with the
Hofmeister order: SO4
2.H2PO4
2.Cl
2 [42].
The peculiar effect of the sulfate anion in promoting
aggregation has also an in vivo biologically relevance due to the
involvement of sulfonated glycosaminoglycans (GAGs) in amyloid
fibril formation of several proteins (ex. light-chain [21,45,46,47],
b2-microglobulin [48], transthyretin [49], human muscle acylpho-
sphatase [50], gelsolin [51]). Despite the large number of reported
evidences, a clear explanation of the mechanism by which GAGs
and sulfate anion promote aggregation is still lacking. In this work,
we show that not only fibrillation but also aggregation into
amorphous aggregates is accelerated by the sulfate anion. The
peculiar effect of the sulfate may be explained considering several
Figure 7. FTIR secondary structure analysis. Thin film ATR-FTIR
spectra of native light chain dimer (–) and of light chain aggregates
obtained after one month incubation in 20 mM HCl at pH 2.0 with
0.45 M NaCl (_), with 0.15 M Na2SO4 (...), or with 0.49 M NaH2PO4 ({:{)
(runs 4, 8, and 6 in Table 1).
doi:10.1371/journal.pone.0033372.g007
Figure 8. Scheme of aggregation mechanism. D* represents the
salt-induced or temperature-induced intermediate dimer prone to
aggregate.
doi:10.1371/journal.pone.0033372.g008
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screening of electrostatic repulsion of a bivalent anion is larger
with respect to monovalent anions; 2) a bivalent anion can act as a
bridge between two positively charged proteins favoring their
aggregation [52]; 3) according to the Hofmeister series, sulfate is
the most kosmotropic anion with the largest propensity to induce
salting-out effect without changing the native structure; 4) the
bivalency promotes a more effective anion binding, which may
significantly changes intramolecular interactions, stabilizing an
unfolded intermediate with respect to the native state. The
experimental results indicate that, at least for the dimer
investigated in this work, at low pH the last one of the above
effects is predominant: sulfate anion binding induces a disruption
of the b–sheet structure of the immunoglobulin variant into a
more disordered structure, which apparently exhibits larger
propensity to aggregate. It is worth noting that at physiological
pH the protein has a lower net positive charge and anion binding
is significantly reduced. Indeed, no aggregation was observed at
physiological pH, even in presence of Na2SO4 or GuHCl.
Concluding remarks
In this work, a non-amyloidogenic light chain dimer has been
expressed in human myeloma cell line U266 adapted to low serum
media, and its in vitro aggregation behavior has been investigated.
Moreover, the light chain sequence has been characterized in
order to allow comparative analysis with other studies describing
the features of amyloidogenic light chains with a known sequence.
It is found that the dimer is very stable in physiological
conditions and aggregation is observed only when specific
denaturing conditions are applied.
Aggregation starts immediately without any lag phase or
nucleation process and forms spherical, amorphous aggregates.
The impossibility to obtain fibrils in vitro from a light chain dimer
has a significant relevance also for the in vivo systems, suggesting
that the presence of light chain monomer is fundamental for the
formation of amyloid fibrils, while dimers are responsible for
oligomers or amorphous deposits.
It is found that at low pH the salt anion has a significant specific
effect on protein aggregation kinetics according to the following
order: SO4
2&Cl
2.H2PO4
2. In particular, the sulfate anion
accelerates aggregation by inducing protein secondary structure
change.
Materials and Methods
Cell growth, protein purification and characterization
The IgE l light chain was produced from the human mammalian
cell line U266 obtained from a 53-years-old patient suffering from
multiple myeloma [14]. Cells were received from the institute
‘‘Mario Negri’’ (Milan, Italy) in RPMI-1640 medium (Sigma-
Aldrich, Steinheim, DE) with addition of 10% fetal bovine serum
(FBS) (PAN Biotech, Mu ¨nchen, DE) and 0.1% Penicillin-Strepto-
mycin Solution (Sigma-Aldrich, Steinheim, DE) to avoid bacterial
contaminations. The cellswereadapted from the 10%FBS medium
to a 1% FBS medium to simplify the purification step.
The collected supernatant containing the desired product was
concentrated 10-fold using a SartoflowH Slice 200 Benchtop
Crossflow system with 10 kDa cut-off membrane (Sartorius
GmbH, Go ¨ttingen, DE). The concentrated cell culture superna-
tant was then prepared for cation exchange chromatography by
three-fold dilution with deionized water for decreasing the ionic
strength and by adjusting the pH to a value in the range 5.0–5.5
using glacial acetic acid (Carbo Erba Reagents, Rodano, Italy).
The solution was then filtered using the SartoflowH Slice 200
Benchtop Crossflow system with 200 nm cut-off membrane.
The clarified cell culture supernatant was then purified by
combining cation exchange chromatography with size exclusion
chromatography (SEC). In principle, pure protein can be obtained
using a SEC column alone. However, since the SEC technique can
operate only at a relatively low flow rate and only a limited amount
of material can be loaded, it has extremely low productivity.
Therefore, we have developed a cation-exchange process to purify
and simultaneously concentrate the IgE l light chain fragment. All
preparative chromatography steps were operated on AKTA
equipment (GE Healthcare, Uppsala, SE). The cation-exchange
step was carried out using Poros HS50 (Applied Biosystems,
Hercules, CA, USA), packed into a KronLab TAC 15/125G0-SR
column with 1.5 cm inner diameter and 7.6 cm length. The
chromatography method included a loading step at 10 mL/min
(340 cm/h)anda lineargradientelutionstep from 0–100%bufferB
in 10 min at 9 mL/min (305 cm/h). As mobile phases, 25 mM
acetate buffer (pH 5.0, buffer A) and 25 mM acetate buffer
containing 1 M NaCl (pH 5.0, buffer B) were used. The gradient
elution was fractionated and the purity of the fractions was
determined by analytical SEC on a HP Agilent Series 1100
equipped with a Superdex 75 10/300 GL column (GE Healthcare,
Uppsala, SE). The fractions with the largest content of l light chains
were pooled, concentrated and injected into a HiLoad
TM 26/60
Superdex
TM 75 prep grade column (GE Healthcare, Uppsala, SE).
The fractions with the largest content of l light chain were washed
four times with 25 mM PBS (pH 7.4, 1 g/L NaN3)a n d
concentrated to reach a final concentration of 1 g/L and stored
in refrigeration. With this process, from 6 litres of supernatant we
can obtain 15 mg of l chain with a purity of 97%, where bovine
serum albumin is the main impurity. Three batch productions
indicated good reproducibilityofthe developedpurificationprocess.
The protein concentration was evaluated using a PierceH BCA
Protein Assay Kit (Thermo scientific, Rockford, IL, USA) and UV
absorbance at 280 nm.
The protein purity was assessed by SDS-PAGE with silver
staining and Western blot analysis. For the latter, the monoclonal
anti-human lambda light chain (bound and free) antibody
produced in mouse (Sigma-Aldrich, Steinheim, DE) and the
HRP-linked anti-alpha microglobulin antibody were used as
primary and secondary antibody, respectively.
To measure protein charge properties, a protein stock solution
sample was loaded into an IEF gel (pH 3–10) and run in a
PhastSystem
TM instrument (GE Healthcare, Buckinghamshire, UK).
Mass Spectrometry (MS)
The mass spectrometric analysis was performed on Bruker’s
ESI-Qq-TOF (Bruker, Billerica, MA, USA). The protein samples
at pH 2.7 and 7.4 were ionized by a nano-spray source (Advion’s
NanoMate, Ithaca, NY, USA). The highly protonated mass
spectra were then deconvoluted by the MaxEnt aglorithm to
provide singly-charged molecular mass (MH+).
Circular dichroism (CD)
Circular dichroism (CD) spectra were measured using a Jasco-
815 CD spectrophotometer (Jasco, Easton, MD, USA). Far-UV
CD spectra of 0.3 g/L protein solutions were recorded from 260
to 190 nm with the temperature of the cell holder controlled at
20uC. A quartz cuvette with 0.1 cm path length was used. Spectra
obtained after buffer subtraction were corrected for protein
concentration and smoothed using the Savitsky-Golay function.
Protein thermal stability was evaluated by recording the spectra
at several temperatures and monitoring the change in mean
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20uCt o8 0 uCi n5 uC steps. The solution was equilibrated at each
temperature for 10 min before measuring.
The fraction of unfolded conformation (Fu) was obtained
assuming a two-state folding mechanism according to Equation 1:
Fu~ hf{h
  
= hf{hu
  
ð1Þ
where hf and hu represent the mean residue ellipticity values
characteristic of folded and fully unfolded protein. From the
sigmoidal curve-fit to experimental data the melting temperature
(Tm) was evaluated.
Intrinsic Tryptophan Fluorescence (Trp) and 8-anilino-1-
naphthalenesulfonic acid (ANS) binding
Intrinsic Tryptophan Fluorescence (Trp) measurements were
performed on a Varian Cary Eclipse Fluorescence Spectropho-
tometer (Varian, Palo Alto, CA, USA). Intrinsic tryptophan
fluorescence analysis was performed exciting the sample at
295 nm and collecting emission spectra between 305 and
450 nm. The effect of denaturant on conformational stability
was investigated by incubating 0.8 g/L light-chain solutions in
25 mM PBS buffer at pH 7.4 with 0.15 M NaCl and with
guanidine hydrochloride (GuHCl) in the concentration range from
0t o5Ma t2 5 uC for 40 min. Changes in protein structure were
estimated by fluorescence intensity values assuming a two-state
folding mechanism according to Equation 1. From the sigmoidal
curve-fit to experimental data the midpoint of the unfolding
transition was evaluated (Cm).
8-anilino-1-naphthalenesulfonic acid (ANS) binding experi-
ments were performed using an EnSpire 2300 Multilabel Plate
Reader (Perkin Elmer, Boston, MA, USA). Emission spectra of
0.3 g/L light chain solution in several buffers with 25 mM ANS
were collected at 20uC between 420 and 600 nm using 380 nm as
excitation wavelength.
Dynamic Light Scattering (DLS)
A 10 g/L light chain stock solution was diluted to the desired
concentration (0.3–1 g/L) by the desired investigated buffer
solutions. DLS measurements were performed on-line using a
Zetasizer Nano (Malvern, Malvern Worsc, UK). All samples were
filtered with a 0.02 mm cut-off, Anotop 10 syringe filter (Whatman,
Kent, UK) immediately before the experiment.
Size Exclusion Chromatography (SEC)
The size exclusion chromatography (SEC) technique was
performed with a Superdex 75 10/300 GL, 10 mm6300 mm
size-exclusion column (GE Healthcare, Uppsala, SE) on a Agilent
1200 series HPLC unit (Santa Clara, CA, USA). Each sample was
eluted for 60 min at a constant flow rate of 0.5 mL/min using as
mobile phase a 100 mM Na2SO4,2 5m MN a 2HPO4 solution at
pH 7.4, filtered with a 0.45 mm cut-off, Durapore membrane filter
(Millipore, Billerica, MA, USA). The UV absorbance peaks were
detected at 280 nm and 220 nm.
Field Flow Fractionation (FFF)
The asymmetrical Field Flow Fractionation (FFF) assay was
performed using a AF4 Eclipse 3+ (Wyatt, Dernbach, DE),
coupled with a 1200 Series isocratic pump from Agilent (Santa
Clara, CA, USA). A 275 mm LC channel for aqueous solvents was
used for Eclipse 3, with a trapezoidal spacer (350 mm thick,
26.5 cm long) and a Nadir reg. cellulose membrane with 1 kDa
cut-off at the bottom (Wyatt, Dernbach, DE). The detector flow
was set constant at 1 mL/min, and a step gradient of cross flow
from 5 mL/min to 0 mL/min was applied after 30 min. 20 mM
HCl buffer solution at pH 2.0 was used as mobile phase, after
filtration through a 0.1 mm cut-off, Durapore membrane filter
(Millipore, Billerica, MA, USA). 25 mL of sample were injected at
desired time interval.
Atomic Force Microscope (AFM)
10 mL of 30 fold diluted samples were spotted on a freshly
cleaved mica surface for 30 seconds before washing with Millipore
water to remove unattached material and gently drying under
nitrogen flux. Samples were imaged at room temperature by a
Nanoscope IIIa (Digital Instrument, USA) operating in tapping
mode. Scan rate of 0.8 Hz and antimony doped silicon cantilevers
with resonance frequency in the range 325–382 kHz and tip
radius of 8 nm (Veeco, Plainview, NY, USA) were used.
Fourier Transform Infrared Spectroscopy (FTIR)
Hydrated thin film attenuated total reflectance fourier trans-
form infrared spectroscopy (ATR-FTIR) spectra were acquired on
a Nicolet Nexus 870 FTIR ESP instrument equipped with a ATR
Nicolet Omni-Sampler device (Nicolet, Madison, WI, USA).
Aliquots of 10 mL were spotted on the crystal surface and let
drying under nitrogen flux. The spectra were collected in the
wavelength range from 1700 to 1600 cm
21 at 1 cm
21 resolution
and smoothed using the Savitsky-Golay function after buffer
subtraction.
Supporting Information
Text S1 Characterization of the IgE l light chain sequence in
U266 cells, aggregation stability of light chain under several
conditions followed by dynamic light scattering, and Thioflavin T
(ThT) and Congo Red binding assay.
(DOC)
Figure S1 U266 derived IgE l light chain nucleotide sequence.
Black: variable region; Gray: junction region; underscore: constant
region.
(TIF)
Figure S2 Deduced amino acid sequence of the IGLV2-8
derived U266 l light chain variable region. Amino acid changes
from the germline donor, IGVL2-8, are highlighted. FR:
framework region; CDR: complementarity determining region.
(TIF)
Figure S3 Time evolution of light scattering intensity for run 1
(6), run 7 (*), run 9 (D), run 11 (N), run 12 (e), run 13 (%) and run
14 (#) in Table 1.
(TIF)
Figure S4 Time evolution of ThT fluorescence values (¤) and
DLS intensity (#) under the conditions of Run 8 in Table 1. Insert
represents ThT values at longer incubation times.
(TIF)
Figure S5 Congo Red spectrum obtained by the difference
between the samples and the blank solution: light chain aggregates
after 10 h incubation under the conditions of Run 8 in Table 1 (–);
stable light chain solution at pH 7.4 (…); insulin fibrils (_).
(TIF)
Acknowledgments
We thank Mario Negri Institute (Milan, Italy), particularly Ada De Luigi,
for providing U266 cells. We thank also Dr Zhang (MS service, ETH
Aggregation Behavior of a l Light Chain Dimer
PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e33372Zurich) for mass spectroscopy analysis, Dr. Silvia Campioni and Prof. Riek,
Prof. Vorholt, Prof. Spencer and Prof. Aebi (ETH Zurich) for allowing and
assisting, respectively, CD, fluorescence, AFM and Western Blot analysis in
their labs.
Author Contributions
Conceived and designed the experiments: PA TMS HW MS MM.
Performed the experiments: PA MO MB PR. Analyzed the data: PA MS
MM. Wrote the paper: PA MS MM.
References
1. Buxbaum J (1992) MECHANISMS OF DISEASE - MONOCLONAL
IMMUNOGLOBULIN DEPOSITION - AMYLOIDOSIS, LIGHT CHAIN
DEPOSITION DISEASE, AND LIGHT AND HEAVY-CHAIN DEPOSI-
TION DISEASE. Hematology-Oncology Clinics of North America 6: 323–346.
2. Obici L, Perfetti V, Palladini G, Moratti R, Merlini G (2005) Clinical aspects of
systemic amyloid diseases. Biochimica Et Biophysica Acta-Proteins and
Proteomics 1753: 11–22.
3. Buxbaum JN (2001) Abnormal immunoglobulin synthesis in monoclonal
immunoglobulin light chain and light and heavy chain deposition disease.
Amyloid-Journal of Protein Folding Disorders 8: 84–93.
4. Leung N, Gertz MA, Zeldenrust SR, Rajkumar SV, Dispenzieri A, et al. (2008)
Improvement of cast nephropathy with plasma exchange depends on the
diagnosis and on reduction of serum free light chains. Kidney International 73:
1282–1288.
5. Merlini G, Westermark P (2004) The systemic amyloidoses: clearer understand-
ing of the molecular mechanisms offers hope for more effective therapies.
Journal of Internal Medicine 255: 159–178.
6. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human
disease. Annual Review of Biochemistry 75: 333–366.
7. Bellotti V, Mangione P, Merlini G (2000) Review: Immunoglobulin light chain
amyloidosis - The archetype of structural and pathogenic variability. Journal of
Structural Biology 130: 280–289.
8. Sikkink LA, Ramirez-Alvarado M (2008) Biochemical and aggregation analysis
of Bence Jones proteins from different light chain diseases. Amyloid-Journal of
Protein Folding Disorders 15: 29–39.
9. Nieva J, Shafton A, Altobell LJ, Tripuraneni S, Rogel JK, et al. (2008) Lipid-
derived aldehydes accelerate light chain amyloid and amorphous aggregation.
Biochemistry 47: 7695–7705.
10. Sipe JD, ed. Amyloid Proteins. Weinheim, DE: Wiley-VCH. pp 527–569.
11. Kaplan B, Ramirez-Alvarado M, Dispenzieri A, Zeldenrust SR, Leung N, et al.
(2008) Isolation and biochemical characterization of plasma monoclonal free
light chains in amyloidosis and multiple myeloma: a pilot study of intact and
truncated forms of light chains and their charge properties. Clinical Chemistry
and Laboratory Medicine 46: 335–341.
12. Kaplan B, Livneh A, Gallo G (2007) Charge differences between in vivo deposits
in immunoglobulin light chain amyloidosis and non-amyloid light chain
deposition disease. British Journal of Haematology 136: 723–728.
13. Souillac PO, Uversky VN, Millett IS, Khurana R, Doniach S, et al. (2002)
Elucidation of the molecular mechanism during the early events in immuno-
globulin light chain amyloid fibrillation - Evidence for an off-pathway oligomer
at acidic pH. Journal of Biological Chemistry 277: 12666–12679.
14. Nilsson K, Bennich H, Johansso Sg, Ponten J (1970) ESTABLISHED
IMMUNOGLOBULIN PRODUCING MYELOMA (IGE) AND LYMPHO-
BLASTOID (IGG) CELL LINES FROM AN IGE MYELOMA PATIENT.
Clinical and Experimental Immunology 7: 477–&.
15. Wall J, Schell M, Murphy C, Hrncic R, Stevens FJ, et al. (1999)
Thermodynamic instability of human lambda 6 light chains: Correlation with
fibrillogenicity. Biochemistry 38: 14101–14108.
16. Alvarado UR, DeWitt CR, Shultz BB, Ramsland PA, Edmundson AB (2001)
Crystallization of a human Bence-Jones protein in microgravity using vapor
diffusion in capillaries. Journal of Crystal Growth 223: 407–414.
17. Ikeyama S, Nakagawa S, Arakawa M, Sugino H, Kakinuma A (1986)
PURIFICATION AND CHARACTERIZATION OF IGE PRODUCED
BY HUMAN MYELOMA CELL-LINE, U266. Molecular Immunology 23:
159–167.
18. Nilsson K (1971) SYNTHESIS AND SECRETION OF IGE BY AN
ESTABLISHED HUMAN MYELOMA CELL LINE. Clinical and Experi-
mental Immunology 9: 785–&.
19. Gabrielson JP, Brader ML, Pekar AH, Mathis KB, Winter G, et al. (2007)
Quantitation of aggregate levels in a recombinant humanized monoclonal
antibody formulation by size-exclusion chromatography, asymmetrical flow field
flow fractionation, and sedimentation velocity. Journal of Pharmaceutical
Sciences 96: 268–279.
20. Qin ZJ, Hu DM, Zhu M, Fink AL (2007) Structural characterization of the
partially folded intermediates of an immunoglobulin light chain leading to
amyloid fibrillation and amorphous aggregation. Biochemistry 46: 3521–3531.
21. McLaughlin RW, De Stigter JK, Sikkink LA, Baden EM, Ramirez-Alvarado M
(2006) The effects of sodium sulfate, glycosaminoglycans, and Congo red on the
structure, stability, and amyloid formation of an immunoglobulin light-chain
protein. Protein Science 15: 1710–1722.
22. Morris AM, Watzky MA, Finke RG (2009) Protein aggregation kinetics,
mechanism, and curve-fitting: A review of the literature. Biochimica Et
Biophysica Acta-Proteins and Proteomics 1794: 375–397.
23. Nilsson MR (2004) Techniques to study amyloid fibril formation in vitro.
Methods 34: 151–160.
24. Seshadri S, Khurana R, Fink AL (1999) Fourier transform infrared spectroscopy
in analysis of protein deposits. Amyloid, Prions, and Other Protein Aggregates
309: 559–576.
25. Meng XY, Fink AL, Uversky VN (2008) The effect of membranes on the in vitro
fibrillation of an amyloidogenic light-chain variable-domain SMA. Journal of
Molecular Biology 381: 989–999.
26. Souillac PO, Uversky VN, Fink AL (2003) Structural transformations of
oligomeric intermediates in the fibrillation of the immunoglobulin light chain
LEN. Biochemistry 42: 8094–8104.
27. Kim YS, Randolph TW, Stevens FJ, Carpenter JF (2002) Kinetics and
energetics of assembly, nucleation, and growth of aggregates and fibrils for an
amyloidogenic protein - Insights into transition states from pressure, temper-
ature, and co-solute studies. Journal of Biological Chemistry 277: 27240–27246.
28. Kim YS, Cape SP, Chi E, Raffen R, Wilkins-Stevens P, et al. (2001)
Counteracting effects of renal solutes on amyloid fibril formation by
immunoglobulin light chains. Journal of Biological Chemistry 276: 1626–1633.
29. Khurana R, Gillespie JR, Talapatra A, Minert LJ, Ionescu-Zanetti C, et al.
(2001) Partially folded intermediates as critical precursors of light chain amyloid
fibrils and amorphous aggregates. Biochemistry 40: 3525–3535.
30. Kim YS, Wall JS, Meyer J, Murphy C, Randolph TW, et al. (2000)
Thermodynamic modulation of light chain amyloid fibril formation. Journal
of Biological Chemistry 275: 1570–1574.
31. Randles EG, Thompson JR, Martin DJ, Ramirez-Alvarado M (2009) Structural
Alterations within Native Amyloidogenic Immunoglobulin Light Chains.
Journal of Molecular Biology 389: 199–210.
32. Ahmad A, Millett IS, Doniach S, Uversky VN, Fink AL (2004) Stimulation of
insulin fibrillation by urea-induced intermediates. Journal of Biological
Chemistry 279: 14999–15013.
33. Ahmad A, Millett IS, Doniach S, Uversky VN, Fink AL (2003) Partially folded
intermediates in insulin fibrillation. Biochemistry 42: 11404–11416.
34. Chiti F, De Lorenzi E, Grossi S, Mangione P, Giorgetti S, et al. (2001) A
partially structured species of beta(2)-microglobulin is significantly populated
under physiological conditions and involved in fibrillogenesis. Journal of
Biological Chemistry 276: 46714–46721.
35. Roberts CJ (2007) Non-native protein aggregation kinetics. Biotechnology and
Bioengineering 98: 927–938.
36. Calamai M, Chiti F, Dobson CM (2005) Amyloid fibril formation can proceed
from different conformations of a partially unfolded protein. Biophysical Journal
89: 4201–4210.
37. Powers ET, Powers DL (2008) Mechanisms of protein fibril formation:
Nucleated polymerization with competing off-pathway aggregation. Biophysical
Journal 94: 379–391.
38. Raman B, Chatani E, Kihara M, Ban T, Sakai M, et al. (2005) Critical balance
of electrostatic and hydrophobic interactions is required for beta(2)-micro-
globulin amyloid fibril growth and stability. Biochemistry 44: 1288–1299.
39. Baden EM, Owen BAL, Peterson FC, Volkman BF, Ramirez-Alvarado M, et al.
(2008) Altered dimer interface decreases stability in an amyloidogenic protein.
Journal of Biological Chemistry 283: 15853–15860.
40. Souillac PO, Uversky VN, Millett IS, Khurana R, Doniach S, et al. (2002) Effect
of association state and conformational stability on the kinetics of immunoglob-
ulin light chain amyloid fibril formation at physiological pH. Journal of
Biological Chemistry 277: 12657–12665.
41. Arosio P, Barolo G, Mu ¨ller-Spa ¨th T, Wu H, Morbidelli M (2011) Aggregation
stability of a monoclonal antibody in downstream processing. Pharmaceutical
Research 28: 1884–1894.
42. Zhang YJ, Cremer PS (2006) Interactions between macromolecules and ions: the
Hofmeister series. Current Opinion in Chemical Biology 10: 658–663.
43. Curtis RA, Lue L (2006) A molecular approach to bioseparations: Protein-
protein and protein-salt interactions. Chemical Engineering Science 61:
907–923.
44. Bostrom M, Williams DRM, Ninham BW (2004) Why the properties of proteins
in salt solutions follow a Hofmeister series. Current Opinion in Colloid &
Interface Science 9: 48–52.
45. McLaughlin RW, Sikkink LA, Baden EM, Ramirez-Alvarado M (2006) The
effect of glycosaminoglycans on the structure, stability and amyloid formation of
an immunoglobulin light chain protein. Amyloid-Journal of Protein Folding
Disorders 13: 45–46.
46. Stevens FJ, Kisilevsky R (2000) Immunoglobulin light chains, glycosaminogly-
cans, and amyloid. Cellular and Molecular Life Sciences 57: 441–449.
47. Sikkink LA, Ramirez-Alvarado M (2008) Salts enhance both protein stability
and amyloid formation of an immunoglobulin light chain. Biophysical
Chemistry 135: 25–31.
48. Borysik AJ, Morten IJ, Radford SE, Hewitt EW (2007) Specific glycosamino-
glycans promote unseeded amyloid formation from beta(2)-microglobulin under
physiological conditions. Kidney International 72: 174–181.
Aggregation Behavior of a l Light Chain Dimer
PLoS ONE | www.plosone.org 11 March 2012 | Volume 7 | Issue 3 | e3337249. Noborn F, O’Callaghan P, Dacklin I, Ancsin JB, Damas A, et al. (2010)
Heparan sulphate/heparin binds transthyretin and promotes its fibrillogenesis.
Amyloid-Journal of Protein Folding Disorders 17: 40–40.
50. Motamedi-Shad N, Monsellier E, Torrassa S, Relini A, Chiti F (2009) Kinetic
Analysis of Amyloid Formation in the Presence of Heparan Sulfate FASTER
UNFOLDING AND CHANGE OF PATHWAY. Journal of Biological
Chemistry 284: 29921–29934.
51. Suk JY, Zhang FM, Balch WE, Linhardt RJ, Kelly JW (2006) Heparin
accelerates gelsolin amyloidogenesis. Biochemistry 45: 2234–2242.
52. Yang H, Pritzker M, Fung SY, Sheng Y, Wang W, et al. (2006) Anion effect on
the nanostructure of a metal ion binding self-assembling peptide. Langmuir 22:
8553–8562.
Aggregation Behavior of a l Light Chain Dimer
PLoS ONE | www.plosone.org 12 March 2012 | Volume 7 | Issue 3 | e33372